Single-cell and AI technologies to accelerate cell & gene therapy R&D
The Switzerland Innovation Park Basel Area team invites you to join us for an online session with our Site Novartis resident Scailyte. The company’s proprietary best-in-class single-cell data analysis platform ScaiVision is the most powerful and cutting-edge approach used by leading university hospitals and biopharma companies. With their approach, they de-risk R&D processes and deliver deep molecular insights within weeks, compared to many months when using conventional technologies.
During this session, led by our Community Manager Rahel Schneider, you will get the chance to learn about Scailyte’s platform and network with innovators in our healthcare and digital health community.